drugset
drugset / Trial / NCT04772846

Chloroquine for Glioblastoma.

NCT04772846 ↗

Phase 1/2 Unknown 60 enrolled Egyptian Medical Syndicate
RandomizedParallel-groupSingle-blindTreatment

Summary

Adjuvant chloroquine to the conventional treatment for glioblastoma; A randomized, single-blind, placebo-controlled, phase I/II trial.

Timeline

Start
2018-03-01
Primary completion
2020-12-01
Completion
2021-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroquine Small molecule 250 mg Oral

Indications

glioblastoma